Inhaled nitric oxide (NO) is a selective pulmonary vasodilator which ameliorates the hypoxemia and pulmonary hypertension associated with adult respiratory distress syndrome (ARDS). However, in approximately 30% of ARDS patients, NO fails to decrease pulmonary artery pressure or improve oxygenation or both. It is the long term objective of this research to characterize the cellular and molecular mechanisms regulating responsiveness to inhaled NO with the goal of improving the efficacy of this novel therapy. NO acts, at least in part, by stimulating soluble guanylate cyclase (sGC), a heterodimer, to produce the intracellular second messenger cGMP. cGMP activates cGMP-dependent protein kinases (cGDPK) leading to relaxation of vascular smooth muscle. Animal studies have demonstrated a critical role for sGC in the regulation of NO responsiveness. Our preliminary studies revealed that exposure of primary cultures of rat pulmonary artery smooth muscle cells (RPaSMC) to cytokines, NO-donor compounds, and cell-permeable cGMP analogues all decreased sGC subunit gene expression. Similarly, decreased pulmonary sGC subunit gene expression was found in animals breathing low concentrations of NO or exposed to lipopolysaccharide (LPS), which stimulates endogenous NO production. A unifying hypothesis for these observations is that LPS and inflammatory cytokines stimulate NO production and increase pulmonary cGMP levels leading to cGDPK activation and decreased sGC subunit gene expression. Decreased sGC in response to inflammatory conditions, such as acute pulmonary injury, may represent a homeostatic response to increase NO concentrations. The overall objective of the research described in this proposal is to characterize the cellular and molecular aspects of sGC regulation in pulmonary vascular smooth muscle. Specifically, mechanisms involved in the regulation of sGC by NO will be identified in RPaSMC and in rats exposed to LPS or NO. The effect of decreased sGC subunit gene expression associated with chronic NO inhalation on pulmonary vascular responsiveness to NO will be investigated using an isolated-perfused lung system. In addition, molecular mechanisms involved in NO-mediated regulation of sGC subunit gene transcription and/or mRNA stability will be characterized. Increased understanding of the mechanisms regulating pulmonary NO/cGMP signal transduction is expected to lead to the development of novel approaches to the treatment of ARDS.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL055377-04
Application #
6030712
Study Section
Lung Biology and Pathology Study Section (LBPA)
Project Start
1996-07-01
Project End
2001-06-30
Budget Start
1999-07-01
Budget End
2001-06-30
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Hassoun, Paul M; Filippov, Galina; Fogel, Michael et al. (2004) Hypoxia decreases expression of soluble guanylate cyclase in cultured rat pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol 30:908-13
Raveh, Yehuda; Ichinose, Fumito; Orbach, Pini et al. (2002) Radical scavengers protect murine lungs from endotoxin-induced hyporesponsiveness to inhaled nitric oxide. Anesthesiology 96:926-33
Schmidt, U; Han, R O; DiSalvo, T G et al. (2001) Cessation of platelet-mediated cyclic canine coronary occlusion after thrombolysis by combining nitric oxide inhalation with phosphodiesterase-5 inhibition. J Am Coll Cardiol 37:1981-8
Takata, M; Filippov, G; Liu, H et al. (2001) Cytokines decrease sGC in pulmonary artery smooth muscle cells via NO-dependent and NO-independent mechanisms. Am J Physiol Lung Cell Mol Physiol 280:L272-8
Holzmann, A; Manktelow, C; Weimann, J et al. (2001) Inhibition of lung phosphodiesterase improves responsiveness to inhaled nitric oxide in isolated-perfused lungs from rats challenged with endotoxin. Intensive Care Med 27:251-7
Ichinose, F; Zapol, W M; Sapirstein, A et al. (2001) Attenuation of hypoxic pulmonary vasoconstriction by endotoxemia requires 5-lipoxygenase in mice. Circ Res 88:832-8
Roberts Jr, J D; Chiche, J D; Weimann, J et al. (2000) Nitric oxide inhalation decreases pulmonary artery remodeling in the injured lungs of rat pups. Circ Res 87:140-5
Weimann, J; Ullrich, R; Hromi, J et al. (2000) Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension. Anesthesiology 92:1702-12
Bloch, D B; Nakajima, A; Gulick, T et al. (2000) Sp110 localizes to the PML-Sp100 nuclear body and may function as a nuclear hormone receptor transcriptional coactivator. Mol Cell Biol 20:6138-46
Ullrich, R; Scherrer-Crosbie, M; Bloch, K D et al. (2000) Congenital deficiency of nitric oxide synthase 2 protects against endotoxin-induced myocardial dysfunction in mice. Circulation 102:1440-6

Showing the most recent 10 out of 20 publications